Work

Intravenous nicorandil pretreatment improves myocardial strain and attenuates microvascular obstruction in STEMI patients undergoing primary PCI: a randomized, double-blind, placebo-controlled CMR study

Year: 2026
Type: article
Abstract: Myocardial strain provides a sensitive and reliable assessment of myocardial function during the acute phase of ST-segment elevation myocardial infarction (STEMI). Nicorandil has been proposed as a cardioprotective agent, but its effects on myocardial strain have not been systematically evaluated. This study aimed to evaluate the effects of nicorandil on myocardial strain and long-term major adverse cardiovascular events (MACE) in STEMI patients. This post hoc, exploratory single-center substudy of the randomized, double-blind, placebo-controlled CLEAN trial included 73 STEMI patients with evaluable CMR data who had been allocated to intravenous nicorandil ( n = 36) or placebo ( n = 37) before primary PCI. Cardiac magnetic resonance (CMR) was performed at a median of 4 (3, 5) days. MACE were recorded over a median follow-up of 42 (36, 46) months. Compared with the control group, the nicorandil group demonstrated significantly improved global longitudinal strain, global circumferential strain, global radial strain, Left atrial (LA) reservoir strain, and LA booster strain ( P < 0.05), while LVEF did not differ significantly ( P = 0.348). Late gadolinium enhancement, microvascular obstruction (MVO) incidence, and caIMR were all significantly lower in the nicorandil group ( P < 0.05). There was no statistically significant difference in MACE-free survival between groups (log-rank P = 0.186). Among STEMI patients with evaluable CMR, intravenous nicorandil pretreatment before primary PCI was associated with more favorable myocardial strain, smaller infarct size, less MVO, and lower caIMR. These exploratory findings require confirmation. ClinicalTrials.gov, NCT04665648; registered on 02 December 2020.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,090
OpenAlex ID: W7235646122
FWCI:
Cites:
Cited by:
Related to: 10